ArticleESMO open2022

Letter re: Neoadjuvant chemoradiotherapy is superior to chemotherapy alone in surgically treated stage III/N2 non-small-cell lung cancer: a retrospective single-center cohort study.

J Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.